Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

PURPOSE: Circulating tumor cells (CTCs) are prognostic in patients with breast cancer. Several technical platforms exist for their enumeration and characterization. Comparative studies between these platforms are scarce. The RareCyte CTC detection is theoretically more sensitive than the established...

Descripción completa

Detalles Bibliográficos
Autores principales: Dirix, Luc, Buys, Andy, Oeyen, Steffy, Peeters, Dieter, Liègeois, Vincent, Prové, Annemie, Rondas, Dieter, Vervoort, Liesbet, Mariën, Véronique, Laere, Steven Van, Vermeulen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090706/
https://www.ncbi.nlm.nih.gov/pubmed/35397078
http://dx.doi.org/10.1007/s10549-022-06585-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090706/
https://www.ncbi.nlm.nih.gov/pubmed/35397078
http://dx.doi.org/10.1007/s10549-022-06585-5

Ejemplares similares